Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07321587 · ClinicalTrials.gov registry record · NA
Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise
A NA study of Mild Dementia, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07321587: Recruiting NA study of Mild Dementia, sponsored by NYU Langone Health.
NCT07321587 is a NA study of Mild Dementia that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 100 participants, above the 56-participant average among 5 other Mild Dementia trials with a reported enrollment target (79% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07321587, a NA study of Mild Dementia, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multi-methods two-arm, crossover, analyst-blinded randomized controlled trial with embedded qualitative interviews, enrolling 50 dyads (older adult-care partner). Participants will receive the ACTIVE intervention, which includes a Fitbit smartwatch, motivational text messages to engage in walking exercise, instructional educational videos, and virtual physical therapy sessions. Intervention components will be delivered over 3 weeks, with continuous monitoring of physical activity via Fitbit data, read receipts of the motivational text messages, and log of engagement in the virtual physical therapy and educational videos.
Primary Outcome
Measured as the proportion of participants who initiate use of each intervention component: * Smartwatch: device activated and worn for ≥3 days during week 1. * Text reminders: ≥1 responses to text message opened/read in week 1. * Virtual PT videos: at least one session accessed in week 1, which will be tracked online through participant specific username. * Instructional education videos: at least one video accessed in week 1,which will be tracked online through participant specific username.
Conditions Studied
Interventions
- BEHAVIORAL ACTIVE Intervention
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-01-26 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07321587 shows while recruiting
NCT07321587 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 56-participant average among 5 other Mild Dementia trials with a reported enrollment target (79% higher).
The record links to 1 condition, with Mild Dementia appearing as the primary indexed condition, and to 1 intervention - of which ACTIVE Intervention is the first listed.
NCT07321587 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07321587 about?
NCT07321587 is a clinical study titled "Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise". This is a multi-methods two-arm, crossover, analyst-blinded randomized controlled trial with embedded qualitative interviews, enrolling 50 dyads (older adult-care partner). Participants will receive the ACTIVE intervention, which includes a Fitbit smartwatch, motivational text messages to engage in ...
What is the current status of trial NCT07321587?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-01-26. Estimated completion is 2027-12.
What conditions does trial NCT07321587 study?
This clinical trial studies the following conditions: Mild Dementia.
What interventions are being tested in trial NCT07321587?
The interventions under investigation include: ACTIVE Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07321587?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07321587 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Pulse Stimulation of the Brain
RECRUITING · NA
-
SHARE Adaptation Intervention for African-American Families
RECRUITING · NA
-
Assessing Cognitive Decline at Home
RECRUITING
-
NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)
ACTIVE NOT RECRUITING · Phase 2
-
A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI